• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ACLARUBICIN Drug Record

  • Summary
  • Interactions
  • Claims
  • ACLARUBICIN chembl:CHEMBL502620

    Alternate Names:

    ACLARUBICIN HCL
    NSC-208734
    ACLACINOMYCIN A
    ACLARUBICIN

    Drug Info:

    (0 More Sources)

    Publications:

    Andreassi et al., 2001, Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients., Hum. Mol. Genet.
    Nørgaard et al., 1993, Synergistic and antagonistic effects of myeloid growth factors on in vitro cellular killing by cytotoxic drugs., Leuk. Res.
  • ACLARUBICIN   CSF2

    Interaction Score: 0.92

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    7689127


    Sources:
    NCI

  • ACLARUBICIN   TOP2B

    Interaction Score: 0.44

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • ACLARUBICIN   SMN1

    Interaction Score: 0.29

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11734549


    Sources:
    NCI

  • NCI: ACLARUBICIN

    • Version: 14-September-2017

    Alternate Names:
    C202 NCI drug code

    Drug Info:

    Publications:
    Nørgaard et al., 1993, Synergistic and antagonistic effects of myeloid growth factors on in vitro cellular killing by cytotoxic drugs., Leuk. Res.
    Andreassi et al., 2001, Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients., Hum. Mol. Genet.

  • TTD: Aclarubicin

    • Version: 2020.06.01

    Alternate Names:
    D01UBX TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL502620

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21